Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Lifestance Health (LFST)

LifeStance Health director Teresa DeLuca to resign from board effective December 31, 2026

Neutral Impact 2 of 5 leadership Written later

LifeStance Health Group disclosed that director Teresa DeLuca, M.D., notified the board on October 14, 2026, of her resignation from the board and all of its committees, effective December 31, 2026. The company states the resignation is not the result of any disagreement with the company.

Key points

  • Teresa DeLuca, M.D., resigns from the board of directors and all committees.
  • Resignation notified to the board on October 14, 2026, effective December 31, 2026.
  • Company states the resignation does not result from any disagreement with Dr. DeLuca.
  • Filing does not name a replacement director or describe any financial effect.

The filing

CompanyLifestance Health (LFST)
Form8-K, current report
Filed with the SECOct 16, 2026, 5:26 PM ET
Accession number0001193125-26-424294

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 16, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.